A trial sequential meta-analysis of TNF-α –308G>A (rs800629) gene polymorphism and susceptibility to colorectal cancer
Author(s) -
Raju K. Mandal,
Munawwar Ali Khan,
Arif Hussain,
Naseem Akhter,
Arshad Jawed,
Sajad Ahmad Dar,
Mohd Wahid,
Aditya K. Panda,
Mohtashim Lohani,
Bhartendu Nath Mishra,
Shafiul Haque
Publication year - 2018
Publication title -
bioscience reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.938
H-Index - 77
eISSN - 1573-4935
pISSN - 0144-8463
DOI - 10.1042/bsr20181052
Subject(s) - odds ratio , single nucleotide polymorphism , meta analysis , colorectal cancer , snp , medicine , confidence interval , subgroup analysis , genotype , allele , genetic model , oncology , tumor necrosis factor alpha , gastroenterology , gene , genetics , biology , cancer
Tumor necrosis factor-α (TNF-α), secreted by the activated macrophages, may participate in the onset and progression of colorectal cancer (CRC). The association of TNF -α - 308 G>A (rs1800629) single-nucleotide polymorphism (SNP) with CRC risk has been investigated by many studies but the results are inconclusive. A trial sequential meta-analysis was performed for precise estimation of the relationship between TNF -α - 308 G>A gene polymorphism with CRC risk.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom